bf/NASDAQ:DVAX_icon.png

NASDAQ:DVAX

Dynavax Technologies

  • Stock

USD

Last Close

10.99

06/11 21:01

Market Cap

1.39B

Beta: 1.48

Volume Today

1.51M

Avg: 1.39M

PE Ratio

26.94

PFCF: 18.82

OverviewFinancialsAPI

    Description

    Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the ad...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    1020302018-12-312020-03-112022-02-282023-08-032024-10-24

    Revenue (Estimate*)

    50M100M150M200M250M2018-12-312020-03-112022-02-282023-08-032024-10-24

    *Estimate based on analyst consensus